Formerly at NCI and Head of Hematology at Georgetown University Hospital, 5 decades developing new drugs for CLL and lymphoma and establishing response criteria.
Talks (7)
Air Time: 09:03:16
R-glofit-pola in elderly LBCl
Jan 19
Resistance to Pirtobrutinib
Jan 17
Limited duration acalabrutinib
Jan 17
Pirtobrutinib vs BR in CLL
Jan 17
Bexobrutideg in CLL
Jan 17
Pirtobrutinib vs Ibrutinib in CLL
Jan 16
